Grifols Stock News

Spanish drug maker Grifols , battling a plunge in its share price this year, plans to add independent directors to its audit and compensation committees to improve its governance, its chairman said in

Spanish drug maker Grifols plans to meet its debt payments in 2025 with the proceeds of new senior secured notes and the sale of its 20% stake in Shanghai RAAS to Haier Group, it said on Wednesday.

Shares in Spanish drugmaker Grifols fell to a 12-year low on Wednesday, following the publication of a new report by Gotham City Research questioning the financial accounts of the Barcelona-based comp

Shares in Spanish drugmaker Grifols fell nearly 15% in early trading on Wednesday following the publication of a new report by Gotham City Research questioning the Barcelona-based company's "transpare

Grifols' $1.8 billion sale of a 20% stake in Shanghai RAAS will proceed after a due diligence process concluded "satisfactorily", the Spanish drug maker said on Friday.

Spanish pharma group Grifols was silent on the short-selling attack from Gotham City Research in today's annual earnings call. Grifols found itself under scrutiny from US-based Gotham City earlier th

Gotham City Research has once again questioned the Spanish pharma group Grifols' ties with a company called Scranton Enterprises. Gotham via its website has posed a series of incendiary questions, f

Short seller Gotham City Research has renewed its campaign against Spanish pharmaceutical company Grifols, after its responses to Gotham's original hit piece failed to cut the mustard. Gotham's short-

Short-seller fund Gotham City Research on Tuesday issued a second report on Grifols , maintaining some of its questions over the Spanish pharmaceutical company's accounting practices.

Investors with an interest in Medical - Drugs stocks have likely encountered both Grifols (GRFS) and Zoetis (ZTS). But which of these two stocks offers value investors a better bang for their buck rig

Grifols (GRFS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a tre

Investors interested in stocks from the Medical - Drugs sector have probably already heard of Grifols (GRFS) and Zoetis (ZTS). But which of these two stocks presents investors with the better value op

Spanish stock market supervisor said on Tuesday it is analysing the response from drugmaker Grifols to the allegations in a report from short-seller Gotham City which questioned its financial accounts

Grifols will send "very, very soon" its responses to a query made by Spain's CNMV stock market supervisor, in advance of reaching a ten-day deadline that expires next week, Grifols' board member Tomas

Ratings agency S&P on Friday kept its 'B+' rating for Grifols , with a stable outlook for 2024, in a boost for the Spanish pharmaceutical company after a report by short-seller Gotham City Research se